BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38218893)

  • 1. Association of the triglyceride glucose-body mass index with the extent of coronary artery disease in patients with acute coronary syndromes.
    Yang X; Li K; Wen J; Yang C; Li Y; Xu G; Ma Y
    Cardiovasc Diabetol; 2024 Jan; 23(1):24. PubMed ID: 38218893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
    Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
    Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the triglyceride-glucose index with coronary artery disease complexity in patients with acute coronary syndrome.
    Xiong S; Chen Q; Long Y; Su H; Luo Y; Liu H; Chen Y; Feng Q; Peng X; Jiang M; Yu X; Zhang Z; Cai L
    Cardiovasc Diabetol; 2023 Mar; 22(1):56. PubMed ID: 36907849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
    Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
    Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome.
    Mao Q; Zhou D; Li Y; Wang Y; Xu SC; Zhao XH
    Dis Markers; 2019; 2019():6891537. PubMed ID: 31281548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study.
    Cheng Y; Fang Z; Zhang X; Wen Y; Lu J; He S; Xu B
    Cardiovasc Diabetol; 2023 Mar; 22(1):75. PubMed ID: 36997935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
    Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome.
    Wang J; Huang X; Fu C; Sheng Q; Liu P
    Cardiovasc Diabetol; 2022 Sep; 21(1):187. PubMed ID: 36114495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of triglyceride-glucose index with coronary severity and mortality in patients on dialysis with coronary artery disease.
    Xie E; Ye Z; Wu Y; Zhao X; Li Y; Shen N; Guo X; Gao Y; Zheng J
    Eur J Med Res; 2023 Oct; 28(1):437. PubMed ID: 37848993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimate of prevalent ischemic stroke from triglyceride glucose-body mass index in the general population.
    Du Z; Xing L; Lin M; Sun Y
    BMC Cardiovasc Disord; 2020 Nov; 20(1):483. PubMed ID: 33183220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study.
    Zhang Z; Zhao L; Lu Y; Meng X; Zhou X
    Cardiovasc Diabetol; 2023 Jun; 22(1):161. PubMed ID: 37386494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease.
    Xie E; Ye Z; Wu Y; Zhao X; Li Y; Shen N; Gao Y; Zheng J
    Cardiovasc Diabetol; 2023 Oct; 22(1):292. PubMed ID: 37891651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the triglyceride-glucose index and severity of coronary artery disease.
    Wang X; Xu W; Song Q; Zhao Z; Meng X; Xia C; Xie Y; Yang C; Jin P; Wang F
    Cardiovasc Diabetol; 2022 Sep; 21(1):168. PubMed ID: 36050734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
    Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
    Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.